Emerging & Rare Fungal Infections in Solid Organ Transplant Recipients

Newly emerging and rare fungal agents are increasingly reported as genuine pathogens in posttransplant fungal infections. The description ‘emerging’ has been coined for these fungal agents as they have not been traditionally implicated, recognized, or recovered as the etiological agents of fungal infections in immunocompromised patients. An increased understanding of the importance of these emerging and rare fungal pathogens has developed from infections reported in patients with hematological malignancies undergoing chemotherapeutic regimens and conditioning for bone marrow transplantation (1–6).